Skip to content
PharosDiscovery
  • Small Molecules
  • Biologics
  • AI in Drug Discovery
  • Clinical Trials
  • Reviews
Subscribe
  • Small Molecules
  • Biologics
  • AI in Drug Discovery
  • Clinical Trials
  • Reviews
    Linafexor is engineered for rapid systemic clearance, producing a pulse of FXR activation rather than a sustained plateau.
    Small Molecules

    A Drug Designed to Mimic the Body's Own Rhythm Moves Into Phase 3

    Linafexor is built to activate — then disappear. Early data suggest that timing, not just potency, may be what finally makes FXR agonism work.

    Priya Ramanathan, PhD · July 16, 2026

    Latest Research

    Browse all categories →
    ISX-220 pairs a modified GLP-1 analogue with a transient intestinal permeation enhancer, timed to open and reseal within minutes of dosing.
    Clinical Trials

    An Oral GLP-1 That Survives the Gut Just Long Enough

    Peptide drugs don't usually survive stomach acid or cross the intestinal wall. Isthmus Biosciences says a transient permeation enhancer, not a new peptide, is what finally made an oral GLP-1 agonist work in Phase 2.

    Dana Okafor · October 21, 2026

    ALD-9102 was generated by a structure-conditioned diffusion model trained to target the switch-II pocket of KRAS G12D.
    AI in Drug Discovery

    A Generative Model Designed This KRAS Inhibitor. It's Now in Patients.

    ALD-9102 was never screened from a physical library — it was sampled from a diffusion model trained on covalent fragment geometries. Eleven weeks later, it had a crystal structure. Fourteen months later, it had a Phase 1 trial.

    Marcus Webb · September 3, 2026

    The Weekly Dose

    One email, every Friday: the drug discovery results worth reading — small molecules, biologics, and AI-designed candidates, explained without the jargon.

    You're on the list — look for a confirmation email shortly.

    PharosDiscovery

    Independent scientific journalism covering small molecules, biologics, and AI-driven drug discovery — written for researchers, by researchers.

    Categories

    • Small Molecules
    • Biologics
    • AI in Drug Discovery
    • Clinical Trials
    • Reviews

    Follow

    • RSS feed
    • LinkedIn
    • X / Twitter

    © 2026 Pharos Discovery. All rights reserved.

    Built with Astro. Research content cited under its original license — see each article's reference box.